NEW YORK, March 10, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Virtual...
NEW YORK, March 07, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor...
MONTREAL, March 06, 2023 (GLOBE NEWSWIRE) -- Valeo Pharma Inc. (TSX:VPH, OTCQB: VPHIF, FSE: VP2) (“Valeo” or the “Company”), a Canadian pharmaceutical company, today announced that Steve Saviuk...
VALEO PHARMA ENTERS INTO CANADIAN COMMERCIAL SERVICES AGREEMENT WITH VERU FOR SABIZABULIN IN HOSPITALIZED ADULT PATIENTS WITH COVID-19 AT HIGH RISK FOR ACUTE RESPIRATORY DISTRESS SYNDROME...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.045 | 0.045 | 0.045 | 10200 | 0.045 | CS |
4 | -0.015 | -25 | 0.06 | 0.075 | 0.04 | 62287 | 0.05348528 | CS |
12 | -0.07 | -60.8695652174 | 0.115 | 0.115 | 0.04 | 40834 | 0.06213967 | CS |
26 | -0.115 | -71.875 | 0.16 | 0.17 | 0.04 | 59859 | 0.09228192 | CS |
52 | -0.15 | -76.9230769231 | 0.195 | 0.385 | 0.04 | 53325 | 0.13952197 | CS |
156 | -0.655 | -93.5714285714 | 0.7 | 0.7 | 0.04 | 41197 | 0.32444805 | CS |
260 | -0.655 | -93.5714285714 | 0.7 | 0.7 | 0.04 | 41197 | 0.32444805 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales